American Business Times
SEE OTHER BRANDS

The best business and economy news from the United States

American Business Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Business Times.

Press releases published on May 28, 2025

Harfang Intersects 4.5 g/t Au Over 15.6 m and Delineates New High-Grade Mineralized Shoot at Sky Lake, Ontario

Harfang Intersects 4.5 g/t Au Over 15.6 m and Delineates New High-Grade Mineralized Shoot at Sky Lake, Ontario

MONTREAL, May 28, 2025 (GLOBE NEWSWIRE) -- Harfang Exploration Inc. (TSX.V: HAR) (“Harfang” or the “Company”) is pleased to announce additional high-grade intercepts and the second batch of results from the 2025 winter diamond drill program (“Winter …

Sono-Tek Reports Strong Fiscal Year 2025 Financial Results

Sono-Tek Reports Strong Fiscal Year 2025 Financial Results

-Reports Fourth Consecutive Quarter of Revenue above $5 million -FY 2025 Revenue Growth of 4% YOY - Backlog Remains Strong at $8.6 Million - Projecting Continued Revenue Growth and Profitability in the First Half of Fiscal Year 2026 -Conference Today at 11 …

Ocular Therapeutix™ To Close Enrollment This Week for SOL-R, its Second Registrational Trial Evaluating AXPAXLI™ in Wet Age-Related Macular Degeneration

Ocular Therapeutix™ To Close Enrollment This Week for SOL-R, its Second Registrational Trial Evaluating AXPAXLI™ in Wet Age-Related Macular Degeneration

Enrollment for SOL-R, the largest retinal TKI trial to date, supports randomization of at least 555 subjects SOL-1, Ocular’s first registrational trial in wet AMD, completed randomization in December 2024 and retention remains exceptional as the trial …

BeyondSpring Announces Poster Presentation at 2025 ASCO Annual Meeting

BeyondSpring Announces Poster Presentation at 2025 ASCO Annual Meeting

FLORHAM PARK, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing cancer therapies, today announces that it will have a poster …

BPGbio Presents Advances in Spatial Omics Technology and Targeted Protein Degradation Insights at ASMS 2025

BPGbio Presents Advances in Spatial Omics Technology and Targeted Protein Degradation Insights at ASMS 2025

BOSTON, May 28, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered clinical-stage biopharma company, today announced that the company will present groundbreaking research across five sessions at the 72nd American Society for Mass …

Oragenics, Inc. Announces One-for-Thirty Reverse Stock Split

Oragenics, Inc. Announces One-for-Thirty Reverse Stock Split

SARASOTA, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a biotech company advancing innovative treatments for brain-related health conditions, today announced that its Board of Directors (the “ …

Leading Global Manufacturer Requests HPQ’s First Batch of Fumed Silica for Evaluation

Leading Global Manufacturer Requests HPQ’s First Batch of Fumed Silica for Evaluation

MONTREAL, May 28, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company driving innovation in advanced materials and critical process development, is pleased to inform shareholders …

Un fabricant de premier plan a demandé un lot de silice pyrogénée issu du plus récent essai de HPQ, à des fins d’évaluation

Un fabricant de premier plan a demandé un lot de silice pyrogénée issu du plus récent essai de HPQ, à des fins d’évaluation

MONTRÉAL, 28 mai 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), une entreprise technologique spécialisée dans l’innovation en matériaux avancés et dans la mise au point de procédés critiques …

Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee

Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee

If approved, tebipenem HBr could be the first oral carbapenem antibiotic for US patients with complicated urinary tract infections (cUTIs) An estimated 2.9 million cases of cUTIs are treated annually in the US1 with many cases requiring hospitalization, …

Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference

Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference

CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president and …

Y-mAbs Hosts Virtual Radiopharmaceutical R&D Update Highlighting Clinical Progress and Expanded Pipeline

Y-mAbs Hosts Virtual Radiopharmaceutical R&D Update Highlighting Clinical Progress and Expanded Pipeline

Company’s Part A data readout from first-in-human Phase 1 Trial 1001 in patients with recurrent or refractory metastatic solid tumors known to express GD2, validates GD2-SADA as safe, tolerable and able to achieve targeted in vivo conjugation of 177Lu-DOTA …

Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide Alone

Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide Alone

--Phase 2b QUALITY clinical study topline safety data shows that the enobosarm + semaglutide combination had a positive safety profile compared to semaglutide alone-- --Based on Phase 2b QUALITY trial efficacy and safety data, enobosarm 3mg will advance as …

Goliath Mobilizes For Its Largest Drill Program Of 40,000 Meters With 9 Rigs On The Extensive Surebet High-Grade Gold Discovery That Remains Wide Open Golddigger Property, Golden Triangle, B.C.

Goliath Mobilizes For Its Largest Drill Program Of 40,000 Meters With 9 Rigs On The Extensive Surebet High-Grade Gold Discovery That Remains Wide Open Golddigger Property, Golden Triangle, B.C.

Goliath is embarking on its largest drill program to date that is 100% focused on the extensive Surebet high-grade gold discovery totaling 40,000 meters with 9 rigs based on the positive results from the 2024 drill season which has greatly improved the …

[Latest] Global Green and Bio Polyols Market Size/Share Worth USD 12.65 Billion by 2034 at a 9.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value, SWOT Analysis)

[Latest] Global Green and Bio Polyols Market Size/Share Worth USD 12.65 Billion by 2034 at a 9.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, May 28, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Green and Bio Polyols Market Size, Trends and Insights By Type (Polyester Polyols, Polyether Polyols), By Application (PU Rigid Foam, CASE, …

ADVANT Nctm Selects iManage to Power Flexible, Secure Document and Email Management Across Global Legal Practice

ADVANT Nctm Selects iManage to Power Flexible, Secure Document and Email Management Across Global Legal Practice

CHICAGO, May 28, 2025 (GLOBE NEWSWIRE) -- iManage, the company dedicated to Making Knowledge Work™, today announced that ADVANT Nctm, one of Italy’s leading independent law firms, has selected iManage to transform its approach to document and email …

Bitget Launches PFVSUSDT for Futures Trading and Trading Bots

Bitget Launches PFVSUSDT for Futures Trading and Trading Bots

Victoria, Seychelles, May 28th, 2025, Chainwire Bitget, a leading global cryptocurrency exchange and Web3 platform, has officially introduced PFVSUSDT-M perpetual futures for trading on its platform. The new listing supports a maximum leverage of 20x and …

InflaRx Announces Outcome of Interim Analysis for Vilobelimab Phase 3 Trial in Pyoderma Gangrenosum

InflaRx Announces Outcome of Interim Analysis for Vilobelimab Phase 3 Trial in Pyoderma Gangrenosum

JENA, Germany, May 28, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Independent Data Monitoring Committee (IDMC) …

Canadian North Resources Inc. Reports Operational and Financial Results for the First Quarter Ended March 31, 2025

Canadian North Resources Inc. Reports Operational and Financial Results for the First Quarter Ended March 31, 2025

Highlights: Continued evaluation of multiple metal processing technologies to produce market-ready battery-grade nickel and cobalt compounds, copper and PGE metals from a low-cost, low-carbon footprint mine for the Ferguson Lake Ni-Cu-Co PGE Project …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service